Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
SRT-2104 is an experimental drug that was studied by Sirtris Pharmaceuticals as a small-molecule activator of the sirtuin subtype SIRT1. The compound progressed to Phase II human trials for Type II diabetes before development was discontinued, however it continues to be widely used in animal research into the functions of SIRT1.
Overview, Related Topics & Entities
Explore the main themes, entities and connections around SRT-2104. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
sirt1 small-molecule activator sirtuin experimental drug studied sirtris pharmaceuticals subtype compound progressed phase ii human trials type diabetes development discontinued
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| SRT-2104 | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| SRT-2104 | CAS Number | 1093403-33-8 | 1.00 | infobox |
| SRT-2104 | ChEMBL | ChEMBL4297436 | 1.00 | infobox |
| SRT-2104 | ChemSpider | 28637794 | 1.00 | infobox |
| SRT-2104 | CompTox Dashboard (EPA) | DTXSID00648729 | 1.00 | infobox |
| SRT-2104 | DrugBank | DB12186 Y | 1.00 | infobox |
| SRT-2104 | Formula | C26H24N6O2S2 | 1.00 | infobox |
| SRT-2104 | Molar mass | 516.64 g·mol−1 | 1.00 | infobox |
| SRT-2104 | PubChem CID | 25108829 | 1.00 | infobox |
| SRT-2104 | UNII | 4521NR0J09 | 1.00 | infobox |
| SRT-2104 | is a | experimental drug that was studied by Sirtris Pharmaceuticals as a small-molecule activator of the sirtuin subtype SIRT1 | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.